In CKD patients, Fliser et al. [47] and Komaba et al. [48] also did not find a major role of s-Klotho as an endogenous regulatory hormone or biomarker in CKD when compared to the data available on FGF-23. This evidence concerns the gene KL and chronic kidney disease.